The RANKL/RANK/OPG signaling pathway plays a critical role in osteoclastogenesis and bone remodeling. The associations between sequence variants of the osteoprotegerin (OPG) gene and osteoporosis risk have been widely investigated but remain inconclusive.
Objective:
We performed a meta-analysis to evaluate the associations between OPG gene variants and osteoporosis risk.
Methods:
We searched electronic databases and included studies meeting inclusion criteria. The genetic associations of four common OPG variants, A163G, T245G, T950C, and G1181C, with osteoporosis risk were explored. Pooled odds ratios (OR) and 95% confidence intervals (95% CI) were calculated for multiple genetic models. Subgroup analyses including ethnicity, gender, menopausal status, sample size, and control source were also performed.
Results:
Twenty-six studies comprising 4879 osteoporosis cases and 5708 controls were included. The A163G variant was found to be significantly associated with an increased risk of osteoporosis under both the allelic (G vs. A: OR = 1.45, 95% CI 1.29-1.64, p < 0.001) and dominant models (GG+GA vs. AA: OR = 1.48, 95% CI 1.29-1.70, p < 0.001). Significant associations were also found between the T245G variant and osteoporosis risk. In addition, we observed a reduced risk of osteoporosis in women with the CC genotype at T950C (OR = 0.76, 95% CI 0.64-0.89, p = 0.001) and among Caucasians with the GG or CG genotypes at the G1181C locus (OR = 0.78, 95% CI 0.64-0.94, p = 0.010). In postmenopausal women, only the GG/GA genotypes at the A163G variant were more predisposed to osteoporosis (OR = 1.31, 95% CI 1.00-1.71), whereas CC/CG carriers of G1181C locus may have reduced risk (OR = 0.83, 95% CI 0.66-1.03).
Conclusions:
Common variants of the OPG gene are associated with osteoporosis risk, especially in the Caucasian population and in the female subgroup. These genetic markers could potentially be used as predictive markers for osteoporosis.
Get full access to this article
View all access options for this article.
References
1.
AbdiS, BinbazRA, MohammedAK, et al. (2021) Association of RANKL and OPG gene polymorphism in Arab women with and without osteoporosis. Genes (Basel), 12:200.
2.
BonfaAC, SeguroLP, CaparboV, et al. (2015) RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus. Osteoporos Int, 26:1563-1571.
3.
BoronD, KotrychD, Bartkowiak-WieczorekJ, et al. (2015) Polymorphisms of OPG and their relation to the mineral density of bones in pre- and postmenopausal women. Int Immunopharmacol, 28:477-486.
4.
Brambila-TapiaAJ, Duran-GonzalezJ, Sandoval-RamirezL, et al. (2012) MTHFR C677T, MTHFR A1298C, and OPG A163G polymorphisms in Mexican patients with rheumatoid arthritis and osteoporosis. Dis Markers, 32:109-114.
5.
BucayN, SarosiI, DunstanCR, et al. (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev, 12:1260-1268.
6.
CortetB (2011) Bone repair in osteoporotic bone: postmenopausal and cortisone-induced osteoporosis. Osteoporos Int, 22:2007-2010.
7.
CvijeticS, GrazioS, KosovicP, et al. (2016) Osteoporosis and polymorphisms of osteoprotegerin gene in postmenopausal women—a pilot study. Reumatologia, 54:10-13.
8.
DougallWC (2012) Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. Clin Cancer Res, 18:326-335.
9.
FieldsAJ, KeavenyTM (2012) Trabecular architecture and vertebral fragility in osteoporosis. Curr Osteoporos Rep, 10:132-140.
10.
Gonzalez-MercadoA, Sanchez-LopezJY, Perea-DiazFJ, et al. (2019) Association of polymorphisms of the TNFRSF11B and TNFSF11 genes with bone mineral density in postmenopausal women from western Mexico. Arch Med Sci, 15:1352-1356.
11.
GuoL, TangK, QuanZ, et al. (2014) Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis. DNA Cell Biol, 33:29-39.
12.
HussienYM, ShehataA, KaramRA, et al. (2013) Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. Mol Biol Rep, 40:3675-3680.
13.
KimJG, KimJH, KimJY, et al. (2007) Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause, 14:913-918.
14.
LaceyDL, TimmsE, TanHL, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 93:165-176.
15.
LangdahlBL, CarstensM, StenkjaerL, et al. (2002) Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. J Bone Miner Res, 17:1245-1255.
16.
LeeYH, WooJH, ChoiSJ, et al. (2010) Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. Mol Biol Rep, 37:227-234.
17.
LiS, JiangH, DuN (2017) Association between osteoprotegerin gene T950C polymorphism and osteoporosis risk in the Chinese population: evidence via meta-analysis. PLoS One, 12:e0189825.
18.
LiXR (2009) Association between OPG gene polymorphisms and osteoporosis in elderly men. Shangdong Med J, 49:71-72.
19.
LiuJ, MiaoYD, ZhangYJ, et al. (2010) The study of the association between T950C gene polymorphism in the promoter region of osteoprotegerin and bone mineral density in postmenopausal women. Chin J Osteoporos, 16:184-187.
20.
LiuW, ZhangX (2015) Receptor activator of nuclear factor-kappaB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review). Mol Med Rep, 11:3212-3218.
21.
LuoY, HuZ, HaoJ, et al. (2014) Significant associations between the A163G and G1181C polymorphisms of the osteoprotegerin gene and risk of osteoporosis, especially in postmenopausal women: a meta-analysis. Genet Test Mol Biomarkers, 18:211-219.
22.
Mencej-BedracS, PrezeljJ, MarcJ (2011) TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women. Maturitas, 69:263-267.
23.
MoffettSP, OakleyJI, CauleyJA, et al. (2008) Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women. J Clin Endocrinol Metab, 93:2002-2008.
24.
Mydlarova BlascakovaM, BlascakovaL, PoracovaJ, et al. (2017) Relationship between A163G osteoprotegerin gene polymorphism and other osteoporosis parameters in Roma and non-Roma postmenopausal women in eastern Slovakia. J Clin Lab Anal, 31:e22093.
25.
Mydlarova BlascakovaM, MydlarJ, PetrejcikovaE, et al. (2021) Preliminary results of ethnic divergence of G1181C (rs2073618) and C290T (rs9525641) OPG gene polymorphisms in groups of postmenopausal Slovak women. Eur Rev Med Pharmacol Sci, 25:2182-2192.
26.
Nava-ValdiviaCA, Saldana-CruzAM, Corona-SanchezEG, et al. (2017) Polymorphism rs2073618 of the TNFRSF11B (OPG) gene and bone mineral density in Mexican women with rheumatoid arthritis. J Immunol Res, 2017:7680434.
27.
PengY, ShengX, XueF, et al. (2018) The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: a meta-analysis. Medicine (Baltimore), 97:e13507.
28.
PereiraRMR, FigueiredoCP, ChaCC, et al. (2016) Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH). Osteoporos Int, 27:3319-3329.
29.
RichardsJB, RivadeneiraF, InouyeM, et al. (2008) Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet, 371:1505-1512.
30.
RivadeneiraF, StyrkarsdottirU, EstradaK, et al. (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet, 41:1199-1206.
31.
Seremak-MrozikiewiczA, TatuskoJ, DrewsK, et al. (2009) [Polymorphism of osteoprotegerin gene and osteoporosis in postmenopausal women]. Ginekol Pol, 80:354-360.
32.
ShangM, LinL, CuiH (2013) Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. Clin Biochem, 46:1493-1501.
33.
ShengX, CaiG, GongX, et al. (2017) Common variants in OPG confer risk to bone mineral density variation and osteoporosis fractures. Sci Rep, 7:1739.
34.
SimonetWS, LaceyDL, DunstanCR, et al. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell, 89:309-319.
35.
SongJF, JingZZ, HuW, et al. (2013) Association between single nucleotide polymorphisms of the osteoprotegerin gene and postmenopausal osteoporosis in Chinese women. Genet Mol Res, 12:3279-3285.
36.
SozenT, OzisikL, BasaranNC (2017) An overview and management of osteoporosis. Eur J Rheumatol, 4:46-56.
37.
StangA (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25:603-605.
38.
StyrkarsdottirU, HalldorssonBV, GretarsdottirS, et al. (2008) Multiple genetic loci for bone mineral density and fractures. N Engl J Med, 358:2355-2365.
39.
StyrkarsdottirU, HalldorssonBV, GretarsdottirS, et al. (2009) New sequence variants associated with bone mineral density. Nat Genet, 41:15-17.
40.
SuiMS, NaSP, XieRJ, et al. (2008) Relationship between the polymorphism of T149C and T950C in osteoprotegerin gene and the glucocorticoid-induced osteoporosis. Chin J Blood Purif, 7:375-379.
41.
TangH, ZhuXW, WuLF, et al. (2019) Integrative analysis confirmed the association between osteoprotegerin and osteoporosis. Chin Med Sci J, 34:147-156.
42.
TrajanoskaK, RivadeneiraF (2019) The genetic architecture of osteoporosis and fracture risk. Bone, 126:2-10.
43.
VidalC, BrincatM, Xuereb AnastasiA (2006) TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta. Maturitas, 53:386-395.
44.
VidalC, FormosaR, Xuereb-AnastasiA (2011) Functional polymorphisms within the TNFRSF11B (osteoprotegerin) gene increase the risk for low bone mineral density. J Mol Endocrinol, 47:327-333.
45.
WangC, ZhangZ, ZhangH, et al. (2012) Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. J Bone Miner Res, 27:2582-2591.
46.
WangF, CaoY, LiF, et al. (2014) Association analysis between g.18873C>T and g.27522G>A genetic polymorphisms of OPG and bone mineral density in Chinese postmenopausal women. Biomed Res Int, 2014:320828.
47.
WuF, ZhouD, ShenG, et al. (2019a) Association of VDR and OPG gene polymorphism with osteoporosis risk in Chinese postmenopausal women. Climacteric, 22:208-212.
48.
WuS, LiZ, ZhangJ, et al. (2019b) The genetic association between osteoprotegerin gene polymorphisms and fracture risk in Chinese Han population. J Cell Physiol, 234:20603-20607.
49.
WuZZ, LiuM (2006) The effect of low-body weight combined with T149C and A163G polymorphism of osteoprotegerin promoter region on osteoporosis. Chin J Geriatrics, 25:645-650.
50.
WuZZ, FengJQ, LiuM, et al. (2007) The relationship between body fat ratio combined with G209A and T245G polymorphism of osteoprotegerin promoter region and osteoporosis. Chin J Geriatrics, 12:2409-2413.
51.
XiongDH, LiuXG, GuoYF, et al. (2009) Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet, 84:388-398.
52.
YasudaH, ShimaN, NakagawaN, et al. (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology, 139:1329-1337.
53.
Zavala-CernaMG, Moran-MoguelMC, Cornejo-ToledoJA, et al. (2015) Osteoprotegerin polymorphisms in a Mexican population with rheumatoid arthritis and generalized osteoporosis: a preliminary report. J Immunol Res, 2015:376197.
54.
ZhangL, ChoiHJ, EstradaK, et al. (2014) Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. Hum Mol Genet, 23:1923-1933.
55.
ZhaoHY, LiuJM, NingG, et al. (2005) The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Osteoporos Int, 16:1519-1524.
56.
ZhaoJJ, FengDH, ChengL, et al. (2014) Association analysis between the OPG g.27667T>A genetic variant and bone mineral density in Chinese postmenopausal women. Genet Mol Res, 13:7332-7338.
57.
ZwartM, AzagraR, EncaboG, et al. (2011) Measuring health-related quality of life in men with osteoporosis or osteoporotic fracture. BMC Public Health, 11:775.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
